Qube Research & Technologies LTD Inovio Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.58 $336,653 - $513,839	-885,930 Reduced 93.83%	58,260 $22,000
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $214,468 - $516,924	549,920 Added 139.48%	944,190 $424,000
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $311,473 - $753,055	394,270 New	394,270 $323,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $183,645 - $308,657	-110,630 Reduced 53.5%	96,137 $166,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $262,121 - $724,475	182,029 Added 735.83%	206,767 $358,000
Q1 2022 May 09, 2022	SELL	$2.97 - $5.2 $184,906 - $323,741	-62,258 Reduced 71.56%	24,738 $89,000
Q4 2021 Feb 01, 2022	BUY	$4.99 - $7.46 $434,110 - $648,990	86,996 New	86,996 $434,000
Q1 2020 May 15, 2020	SELL	$2.98 - $14.09 $30,390 - $143,689	-10,198 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.97 - $3.72 $20,090 - $37,936	10,198 New	10,198 $34,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.